Voyager Therapeutics' TRACER Capsids Demonstrate Enhanced CNS Transduction Across Species New Preclinical Results Bolster GBA1, Tau, SOD1 ALS Gene Therapy Programs

  • Mathieu Nonnenmacher

Press/Media

Period19 May 2022

Media coverage

1

Media coverage

  • TitleVoyager Therapeutics' TRACER Capsids Demonstrate Enhanced CNS Transduction Across Species New Preclinical Results Bolster GBA1, Tau, SOD1 ALS Gene Therapy Programs
    Media name/outletMENAFN -Press Releases (English)
    Country/TerritoryJordan
    Date19/05/22
    PersonsMathieu Nonnenmacher
View all 1
View less